Correlation Between Day One and ArriVent BioPharma,
Can any of the company-specific risk be diversified away by investing in both Day One and ArriVent BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and ArriVent BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and ArriVent BioPharma, Common, you can compare the effects of market volatilities on Day One and ArriVent BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of ArriVent BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and ArriVent BioPharma,.
Diversification Opportunities for Day One and ArriVent BioPharma,
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Day and ArriVent is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and ArriVent BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ArriVent BioPharma, and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with ArriVent BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ArriVent BioPharma, has no effect on the direction of Day One i.e., Day One and ArriVent BioPharma, go up and down completely randomly.
Pair Corralation between Day One and ArriVent BioPharma,
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the ArriVent BioPharma,. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 1.1 times less risky than ArriVent BioPharma,. The stock trades about -0.21 of its potential returns per unit of risk. The ArriVent BioPharma, Common is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 2,808 in ArriVent BioPharma, Common on September 15, 2024 and sell it today you would lose (136.00) from holding ArriVent BioPharma, Common or give up 4.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. ArriVent BioPharma, Common
Performance |
| Timeline |
| Day One Biopharmaceu |
| ArriVent BioPharma, |
Day One and ArriVent BioPharma, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and ArriVent BioPharma,
The main advantage of trading using opposite Day One and ArriVent BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, ArriVent BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will offset losses from the drop in ArriVent BioPharma,'s long position.| Day One vs. Puma Biotechnology | Day One vs. Iovance Biotherapeutics | Day One vs. Inozyme Pharma | Day One vs. Zentalis Pharmaceuticals Llc |
| ArriVent BioPharma, vs. Aegon NV ADR | ArriVent BioPharma, vs. Minerals Technologies | ArriVent BioPharma, vs. Western Digital | ArriVent BioPharma, vs. United States Steel |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |